Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03967093
Title A Study of BXQ-350 in Children and Young Adults With Relapsed Solid Tumors
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bexion Pharmaceuticals, Inc.
Indications

brain cancer

atypical teratoid rhabdoid tumor

embryonal cancer

Advanced Solid Tumor

Therapies

BXQ-350

Age Groups: adult | child
Covered Countries USA


No variant requirements are available.